Common adverse effects of breast cancer

The treatment of breast cancer, which includes surgery, chemotherapy, decomposition, endocrinology and target treatment, may cause some adverse effects. I. Unreactive haemorrhage from surgical treatment: may cause vascular damage during the operation, resulting in haemorrhage. If haemorrhage is high, blood transfusion treatment may be required. Infection: Surgery can cause infection in the form of red and red, pain and fever. If the infection is serious, antibiotic treatment may be required. Pain: Pain may occur at post-operative incisions and can usually be mitigated by the use of painkillers. lymphoid oedema: If an armpit lymphoma cleanup is performed, it may lead to lymphoma oedema, which is manifested in upper limb swelling, pain, restriction of movement etc. The treatment of lymphoid oedema is more difficult and usually requires comprehensive treatment such as physiotherapy, massage, stress therapy, etc. ii. The adverse reaction of chemotherapy is disgusting, vomiting: chemotherapy can stimulate the gastrointestinal tract, causing symptoms of nausea, vomiting, etc. The symptoms can be mitigated by the use of anti-pull drugs. Hair take off: chemotherapy can affect the growth of the fur bladder cell and lead to loss of hair. Hair is usually temporary and grows after chemotherapy. Osteo-marrow inhibition: chemotherapy can inhibit bone marrow blood production, leading to a decrease in white cells, red cells and blood panels. Decreases in white cells may increase the risk of infection, reductions in red cells may lead to anaemia, and reductions in platelets may lead to haemorrhage. Bone marrow inhibition can be treated by using white cell drugs, blood transfusions, etc. Wearyness: chemotherapy can lead to conditions such as fatigue and inactivity and affect the quality of life of patients. Wearyness can be alleviated through rest, appropriate exercise and nutritional support. Heart toxicity: Some chemotherapy drugs may cause heart damage, causing symptoms of heart disorder, heart failure, etc. A cardiac function assessment is required prior to chemotherapy, and the heart function is closely monitored during chemotherapy. Neurotoxicity: Certain chemotherapy drugs may cause damage to the nervous system, causing symptoms such as numbing of hands and feet, stings, and sensory abnormalities. Neurotoxicity can be mitigated by the use of trophic nerve drugs. iii. Unreactive skin reaction of the leachate: The leachate may lead to red skin, itching, skin removal, ulcer, etc. Dermal protections can be used to mitigate skin reactions. Wearyness: The release of treatment can lead to signs of fatigue, inefficiency, and affect the quality of life of patients. Wearyness can be alleviated through rest, appropriate exercise and nutritional support. Radiopneumonia: If the therapeutic part includes the lung, it may cause radiopneumonia in the form of cough, cough and respiratory difficulties. Medicines such as sugar-coated hormones and antibiotics can be used to treat radioactive pneumonia. Radioactive Ephrine Inflammation: If the therapeutic area includes the cuisine, it may cause radioactive circulatory inflammation, which is manifested in pain, difficulty, etc. The use of mucous membrane protections, painkillers, etc. can be used to treat irrigated dysentery. iv. Unreactive tide of endocrine treatment: Endocrine treatment can lead to symptoms such as tidal fever, sweating, and affect the quality of life of patients. The tide can be mitigated by using Chinese medicine and regulating lifestyles. Osteoporosis: Endocrine treatment may lead to osteoporosis and increase the risk of fracture. Osteoporosis can be prevented and treated through calcium supplementation, vitamin D and the use of drugs such as biscular acids. Immoral increase: For patients treated with endocrinology using drugs such as Moxiphine, there may be an increase in membrane increase, increasing the risk of uterine cancer. Periodic gynaecological examinations are required to monitor the thickness of the uterine membrane. Hepatic abnormalities: Endocrine treatment may cause hepatic abnormalities, as shown by signs such as amino enzyme rise and yellow sluice. Hepatic function checks are required on a regular basis and hepatopharmacological treatment is used when necessary. v. Unreactive allergies in target-oriented treatment: Certain target-oriented drugs may cause allergies in the form of rashes, itching, respiratory difficulties, etc. In case of allergies, there is a need for an immediate stoppage and treatment with anti-allergy drugs. Heart toxicity: Some target-oriented drugs may cause heart damage, causing symptoms of heart disorder, heart failure, etc. Cardiac function assessments are required prior to the use of the target on drugs, and the heart function is closely monitored during treatment. Diarrhoea: Target treatment can lead to diarrhoea and affect the quality of life of patients. Diarrhoea can be alleviated by the use of laxatives. High blood pressure: Some target-oriented drugs may result in high blood pressure, requiring regular monitoring of blood pressure and, if necessary, treatment with depressive drugs.